Drugs Pharma

Janssen’s human trials for dengue virus to advance to phase II

Janssen Pharmaceutical Companies, a wholly-owned subsidiary of Johnson & Johnson, announced its first-in-human clinical trial of a compound to treat dengue had entered.

Read More
Health Medical Pharma

Fifty-five nations facing a shortage of health workers: WHO

he WHO has identified 55 nations vulnerable to a shortfall in health workers needed to fulfil the UN’s charter for universal health coverage.

Read More
Drugs Medical Pharma

FDA nod for Pfizer-Biotech vaccine booster for children

The FDA cleared the emergency use of bivalent Pfizer-Biotech COVID-19 vaccine for a single dose booster in children aged six months to four.

Read More
Drugs Pharma

Novo Nordisk follows Eli Lilly on insulin price cuts

Denmark's Novo Nordisk plans to effect a 75% cut in insulin prices in the U.S. market by January 1, 2024.

Read More
Drugs Medical Pharma

Sanofi acquires Provention Bio for $2.9 billion to boost its diabetes portfolio

Sanofi acquires Provention Bio, and its TZIELD, the first disease-modifying treatment for the delay of Stage 3 type 1 diabetes (T1D).

Read More
Drugs Medical Pharma

Pfizer to buy Seagen for $43 billion to fortify cancer portfolio

Pfizer will acquire Seagen for $43 billion to beef up its cancer portfolio, with COVID-19 vaccine sales forecast to plummet.

Read More
Drugs Medical Pharma

Merck says trial hypertension drug enhances patients’ walk time

Merck announced its experimental trial on patients with pulmonary arterial hypertension had led to an extension in walking distance and reduced exacerbating the.

Read More
Health Pharma

World Bank loans India $1 billion to aid healthcare sector

The Indian government and the World Bank signed two agreements to support and enhance the development of the health sector in the south.

Read More
Drugs Medical Pharma

CDC report points finger at Indian firm in Gambia deaths

A probe by the US-based Centres for Disease Control into the deaths of 70 children in Gambia "strongly suggests" cough syrups involving contaminated.

Read More
Drugs Pharma

FDA rejects Cytokinetics heart disease trial drug

Cytokinetics, a US-based biopharmaceutical company, announced the FDA had rejected its new drug application for approving a trial drug to treat heart problems.

Read More